MITSUBISHI GAS CHEMICAL COMPANY, INC.
4182・Prime Market・Chemicals
Business
Mitsubishi Gas Chemical is a comprehensive chemical group consisting of 84 subsidiaries and 31 affiliated companies. Its business is composed of two major segments: the Green Energy & Chemical Division (Methanol, Methanol/Ammonia-based Chemicals, Energy Resources, Aromatic Chemicals, etc.) and the Functional Chemicals Division (Inorganic Chemicals, Engineering Plastics, Optical Materials, Electronic Materials, Life Science & Hygiene-related Products, etc.). The company operates overseas joint-venture methanol businesses in Trinidad and Tobago, Brunei, Saudi Arabia, and elsewhere, and also handles high-performance electronic materials such as BT resin materials for semiconductor packaging and OPE® substrate materials for AI servers. Its major customers span a wide range of industrial fields, including semiconductor and electronic component manufacturers, automotive parts manufacturers, and the food and pharmaceutical industries.
Business Model
While equity-method gains/losses and technology licensing income from overseas joint-venture methanol businesses form the base earnings, sales of functional chemicals and electronic materials produced at domestic and overseas manufacturing sites constitute the main revenue source. The Functional Chemicals Division accounted for net sales of ¥447,999 million (FY2026 (ending March 2026)), with differentiated products such as BT resin and OPE® (U&P Business) driving profit. Capital expenditure stands at approximately ¥71,922 million annually, with growth investment continuing mainly in the ICT domain.
Company Strengths
For BT materials used in semiconductor packaging, capacity expansion work at the Thailand site was completed, achieving increased revenue and profit against a backdrop of expanding demand across a broad range of fields. OPE® substrate materials for AI servers recorded sales volume growth exceeding plan. The Electronic Materials Business drove the increase in revenue and profit of the Functional Chemicals Division in FY2025.
The company holds multiple joint venture methanol manufacturing companies in Trinidad and Tobago, Brunei, Saudi Arabia, Venezuela, and elsewhere, and has also concluded technology licensing agreements (with no fixed term). Through the accumulation of long-term overseas joint ventures since 1979, the company has built a global methanol supply network.
The Group's R&D staff number approximately 1,078 (about 13% of total employees), with total R&D expenses of ¥26,636 million. The in-house developed machine learning tool "MLAB" has been rolled out across the Group, and DX analysis has been strengthened through the additional introduction of a supercomputer. A new research building, "PR-SHIPS," was completed at the Hiratsuka Research Laboratory, expanding the research infrastructure.
ENVALITH's Perspective
Performance Trend
Revenue peaked at ¥813,417 million in FY2024 (ended March 2024) and has declined for two consecutive periods, reaching ¥738,243 million in FY2026 (ending March 2026) (down 4.6% year on year). External factors weighed on results, including declines in the engineering plastics and methanol markets, and softening demand for general-purpose products amid China's economic slowdown. Operating profit fell to ¥45,293 million (down 10.9%), and ordinary profit declined to ¥51,947 million (down 13.9%). An impairment loss on fixed assets of ¥78,448 million was recorded as an extraordinary loss, resulting in a loss before income taxes of ¥16,065 million and a net loss attributable to owners of the parent of ¥40,318 million (a sharp reversal from net profit of ¥45,544 million in the previous period). Comprehensive income was limited to ¥5,080 million (down 89.5%). For FY2027 (ending March 2027), a substantial recovery is projected, premised on the absence of the impairment loss, a recovery in the methanol market, and continued semiconductor demand.
Growth Strategy
In the final year of "Grow UP 2026," the company is completing its focus on the Uniqueness & Presence business and the restructuring of key management businesses
Promoting the concentration of management resources on high-value-added products such as electronic materials (BT materials, OPE®) and semiconductor-related chemical solutions. In FY2026 (ending March 2026), electronic materials achieved increased revenue and profit, and the transition progressed toward a structure in which the Functional Chemicals Division accounts for approximately 95% of consolidated ordinary income. For the next fiscal year, continued revenue growth is expected, premised on ongoing demand for advanced semiconductors.
Asset optimization was carried out through withdrawal from the ortho-xylene chain business and the recognition of impairment losses on fixed assets (totaling ¥78,448 million) in businesses with declining competitiveness such as Meta-xylylenediamine and polycarbonate. From the next fiscal year onward, the reduced depreciation burden is expected to contribute to profit improvement.
With DOE of 3.0% as the medium-term dividend target, an annual dividend of ¥100 (an increase from ¥95 in the previous fiscal year) was implemented even in a phase of net loss. For FY2027 (ending March 2027), an annual dividend of ¥110 is planned. The company aims for a total payout ratio of 50% (including share buybacks) as a medium-term guideline, with a policy of enhancing shareholder returns while maintaining financial soundness.
Continuing efforts toward realizing the Carbopath™ environmentally circular methanol concept and the practical application of CCS. Promoting the creation of growth opportunities through the development of new applications, including increased sales volume of OPE®, a substrate material for AI servers. For the next fiscal year, increased revenue in electronic materials and chemical solutions is expected, premised on continued robust semiconductor demand.
Last updated: July 19, 2026